Please Wait
Applying Filters...
menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Etripamil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Milestone Pharmaceuticals to Present Etripamil Data at ACC
    Milestone Pharmaceuticals to Present Etripamil Data at ACC

    20 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/20/3046176/0/en/Milestone-Pharmaceuticals-to-Present-Clinical-Data-on-Etripamil-at-the-American-College-of-Cardiology.html

    GLOBENEWSWIRE
    20 Mar 2025
    Share Share
    Milestone Pharma Notice of Allowance on New Patent for Etripamil
    Milestone Pharma Notice of Allowance on New Patent for Etripamil

    19 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/02/19/3028736/0/en/Milestone-Pharmaceuticals-Notice-of-Allowance-on-New-U-S-Patent-for-Etripamil.html

    GLOBENEWSWIRE
    19 Feb 2025
    Share Share
    Milestone Pharmaceuticals To Host Investor Event On Feb 25 In NYC
    Milestone Pharmaceuticals To Host Investor Event On Feb 25 In NYC

    28 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/28/3016316/0/en/Milestone-Pharmaceuticals-Provides-2025-Corporate-Outlook-and-Will-Host-Investor-Event-on-February-25-in-NYC.html

    GLOBENEWSWIRE
    28 Jan 2025
    Share Share
    Milestone Pharmaceuticals to Host Investor KOL Event
    Milestone Pharmaceuticals to Host Investor KOL Event

    24 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/24/2952137/0/en/Milestone-Pharmaceuticals-to-Host-Investor-KOL-Event.html

    GLOBENEWSWIRE
    24 Sep 2024
    Share Share
    Milestone Partner Ji Xing Pharma, Positive Result of Ph 3 Study in PSVT in China
    Milestone Partner Ji Xing Pharma, Positive Result of Ph 3 Study in PSVT in China

    07 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/06/2942068/0/en/Milestone-Partner-Ji-Xing-Pharmaceuticals-Ltd-Announces-Positive-Topline-Results-from-the-Phase-3-Study-of-Etripamil-in-PSVT-in-China.html

    GLOBENEWSWIRE
    07 Sep 2024
    Share Share
    Milestone Partner Ji Xing Reports Positive Ph 3 Results For Etripamil In PSVT
    Milestone Partner Ji Xing Reports Positive Ph 3 Results For Etripamil In PSVT

    07 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/06/2942068/0/en/Milestone-Partner-Ji-Xing-Pharmaceuticals-Ltd-Announces-Positive-Topline-Results-from-the-Phase-3-Study-of-Etripamil-in-PSVT-in-China.html

    GLOBENEWSWIRE
    07 Sep 2024
    Share Share